Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $81.44 which represents a slight increase of $2.27 or 2.87% from the prior close of $79.17. The stock opened at $79.17 and ...

Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $78.77 which represents a decrease of $-0.36 or -0.45% from the prior close of $79.13. The stock opened at $78.95 and touched a low ...

Gilead Sciences, Inc. (Nasdaq: GILD) will present new data from the company’s broad lung cancer clinical development program ...

Scientists and journalists share a core belief in questioning, observing and verifying to reach the truth. Science News reports on crucial research and discovery across science disciplines. We ...

Most of the world’s biggest news website saw strong growth in July in what was a bumper month for news. July saw an assassination attempt against Donald Trump, Joe Biden announcing he would not ...

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi (seladelpar) for the treatment of primary biliary ...

The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial Officer, Johanna Mercier; our Chief Medical Officer, Merdad Parsey; and our Chief ...

The speakers on today's call will be our chairman and chief executive officer, Daniel O'Day; our chief commercial officer, ...

The company’s chief medical officer Merdad Parsey said the results “don’t alter the demonstration of efficacy observed with remdesivir” in prior studies, adding that Gilead is waiting to ...

Spain's ambassador has been summoned by Venezuela after a minister called the country a "dictatorship". Edmundo González landed at a military base in Madrid, where he will be granted political ...